NEXI — Neximmune Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Neximmune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10.1	5.03	81.8	34.6	3.2
Net Total Receivables	—	—	—	0.074	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11	8.39	86.3	37.4	5.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.58	2.89	4.43	5.43	1.4
Long Term Notes Receivable
Other Long Term Assets
Total Assets	13.7	11.3	91	43.1	8.59
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.03	27	7.22	10.3	5.08
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.11	27.1	7.27	10.8	5.08
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	10.6	-15.8	83.8	32.3	3.51
Total Liabilities & Shareholders' Equity	13.7	11.3	91	43.1	8.59
Total Common Shares Outstanding